3ave: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:3ave.png|left|200px]]


<!--
==Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1==
The line below this paragraph, containing "STRUCTURE_3ave", creates the "Structure Box" on the page.
<StructureSection load='3ave' size='340' side='right'caption='[[3ave]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
== Structural highlights ==
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
<table><tr><td colspan='2'>[[3ave]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=2dtq 2dtq]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AVE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3AVE FirstGlance]. <br>
or leave the SCENE parameter empty for the default display.
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
-->
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
{{STRUCTURE_3ave|  PDB=3ave  |  SCENE=  }}
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ave FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ave OCA], [https://pdbe.org/3ave PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ave RCSB], [https://www.ebi.ac.uk/pdbsum/3ave PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ave ProSAT]</span></td></tr>
 
</table>
===Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1===
== Disease ==
 
[https://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN] Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:[https://omim.org/entry/254500 254500]. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4.
 
== Function ==
<!--
[https://www.uniprot.org/uniprot/IGHG1_HUMAN IGHG1_HUMAN]
The line below this paragraph, {{ABSTRACT_PUBMED_17368483}}, adds the Publication Abstract to the page
__TOC__
(as it appears on PubMed at http://www.pubmed.gov), where 17368483 is the PubMed ID number.
</StructureSection>
-->
{{ABSTRACT_PUBMED_17368483}}
 
==About this Structure==
[[3ave]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=2dtq 2dtq]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3AVE OCA].  
 
==Reference==
<ref group="xtra">PMID:017368483</ref><references group="xtra"/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Kato, K.]]
[[Category: Large Structures]]
[[Category: Matsumiya, S.]]
[[Category: Kato K]]
[[Category: Nagano, M.]]
[[Category: Matsumiya S]]
[[Category: Otaki, S.]]
[[Category: Nagano M]]
[[Category: Saito, J.]]
[[Category: Otaki S]]
[[Category: Sasakawa, H.]]
[[Category: Saito J]]
[[Category: Satoh, M.]]
[[Category: Sasakawa H]]
[[Category: Shitara, K.]]
[[Category: Satoh M]]
[[Category: Yamaguchi, Y.]]
[[Category: Shitara K]]
[[Category: Yamaguchi Y]]

Latest revision as of 18:57, 4 October 2023

Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1Crystal Structure of the Fucosylated Fc Fragment from Human Immunoglobulin G1

Structural highlights

3ave is a 2 chain structure with sequence from Homo sapiens. This structure supersedes the now removed PDB entry 2dtq. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 2Å
Ligands:, , , ,
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Disease

IGHG1_HUMAN Defects in IGHG1 are a cause of multiple myeloma (MM) [MIM:254500. MM is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection. Amyloidosis may develop in some patients. Multiple myeloma is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Note=A chromosomal aberration involving IGHG1 is found in multiple myeloma. Translocation t(11;14)(q13;q32) with the IgH locus. Translocation t(11;14)(q13;q32) with CCND1; translocation t(4;14)(p16.3;q32.3) with FGFR3; translocation t(6;14)(p25;q32) with IRF4.

Function

IGHG1_HUMAN

3ave, resolution 2.00Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA